PVLA
Palvella Therapeutics, Inc
131.30$
+0.6%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +38.0% | +111.9% | +362.2% | -77.1% | +181.6% | -28.6% | -41.1% | +73.9% | -37.6% | +183.8% | +14.1% | -23.2% | -15.2% | -73.9% | -36.1% | +732.9% | -79.0% | +23.5% | +108.1% | +30.1% | -66.3% | +45.2% | +8.9% | -66.9% | +935.9% | -2.7% | -93.3% | -95.9% | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | +12.6% | -51.5% | – | – | +5.2% | -7.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | +42.9% | -31.8% | +34.7% | -24.2% | -2.4% | +27.0% | +1.9% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +40.0% | +122.5% | – | – | +187.5% | -28.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | +29.2% | -69.2% | +47.1% | +14.4% | -74.1% | +1,316.1% | -2.8% | -93.1% | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.4% | +17.4% | -16.7% | +50.9% | +15.5% | +25.0% | +13.9% | +11.4% | -6.5% | -1.2% | +4.8% | -10.3% | -13.0% | +2.5% | -10.3% | +60.5% | -4.7% | +20.7% | -19.5% | -10.4% | -14.0% | +12.8% | -0.1% | +0.1% | +5.9% | -29.3% | -53.6% | -77.9% | +46.5% | +121.6% | -20.4% | +60.2% | +25.6% | +27.5% | +9.1% | +31.1% | +33.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +89.2% | +28.2% | -3.0% | +108.3% | +8.8% | -11.7% | +14.6% | +32.0% | +61.8% | – | |
| – | +4.1% | -6.0% | +27.7% | +5.1% | +13.5% | +16.1% | +8.6% | +9.6% | -8.1% | +2.1% | +0.2% | -7.5% | -7.3% | +0.5% | -11.4% | +46.9% | -3.2% | +15.6% | -16.1% | -6.6% | -12.2% | +8.5% | +0.1% | +0.6% | +2.3% | -9.1% | -56.8% | -74.1% | +65.3% | +74.1% | -13.7% | +80.3% | +17.5% | +10.0% | +11.1% | +31.4% | +44.1% | – | |
| – | – | – | – | -225.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +49.6% | -277.6% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -50.0% | – | – | – | – | – | – | – | – | +31.3% | +17.0% | +5.4% | -6.8% | +11.4% | +11.5% | +15.2% | +17.3% | +13.2% | – | |
| – | – | – | – | -214.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -370.4% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -82.1% | -1.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -216.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -370.4% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -210.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -313.0% | – | – | – | – | – | – | – | – | -3,309.1% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.